This trial studies an intelligent tutoring system intervention in enhancing genetic risk assessment in underserved Blacks and Latinas at risk of hereditary breast cancer. The intelligent tutoring system intervention (BRCA-gist) is a web-based tutoring system that provides education about hereditary breast and ovarian cancer. BRCA-gist may enhance the knowledge and use of genetic cancer risk assessments in at-risk Latina and Black women.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT03511690.
PRIMARY OBJECTIVES:
I. Adapt BRCA-gist.
II. Test the feasibility, acceptability, and efficacy of BRCA-gist intervention in a two-arm randomized controlled trial (RCT).
SECONDARY OBJECTIVES:
I. Explore differences by ethnicity and health literacy and assess emotional reactions to risk information to inform future affective-tailored interventions.
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM I: Participants use the BRCA-gist web-based tutoring system over 90 minutes.
ARM II: Participants read information about hereditary breast and ovarian cancer (HBOC) and BRCA 1/2 on the National Cancer Institute's (NCI) website over 90 minutes.
After completion of study, participants are followed up at 3 months.
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationMedStar Georgetown University Hospital
Principal InvestigatorAlejandra Hurtado de Mendoza
